Dyne Therapeutics Total Current Assets 2020-2024 | DYN

Dyne Therapeutics total current assets from 2020 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.

Dyne Therapeutics Total Current Assets 2020-2024 | DYN

Dyne Therapeutics total current assets from 2020 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
Related Stocks
Company NameMarket
Cap
Zoetis (ZTS)$79.8B
Takeda Pharmaceutical (TAK)$42.6B
Sandoz Group AG (SDZNY)$19.5B
Merck (MKKGY)$19.1B
Astellas Pharma (ALPMY)$18.3B
United Therapeutics (UTHR)$16.6B
Summit Therapeutics (SMMT)$14B
Neurocrine Biosciences (NBIX)$12.7B
Shionogi (SGIOY)$12B
Catalent (CTLT)$11.1B
Madrigal Pharmaceuticals (MDGL)$7.6B
Orion OYJ (ORINY)$6.7B
Corcept Therapeutics (CORT)$6B
Ionis Pharmaceuticals (IONS)$5.4B
Crinetics Pharmaceuticals (CRNX)$5.2B
PTC Therapeutics (PTCT)$3.3B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.6B
Catalyst Pharmaceuticals (CPRX)$2.6B
Soleno Therapeutics (SLNO)$2.5B
Centessa Pharmaceuticals (CNTA)$2.2B
NewAmsterdam Pharma (NAMS)$1.9B
Xencor (XNCR)$1.8B
Recursion Pharmaceuticals (RXRX)$1.6B
Evotec AG (EVO)$1.6B
BioCryst Pharmaceuticals (BCRX)$1.6B
Harrow (HROW)$1.5B
Indivior (INDV)$1.5B
Guardian Pharmacy Services (GRDN)$1.5B
Ocular Therapeutix (OCUL)$1.4B
ARS Pharmaceuticals (SPRY)$1.4B